ZACTRAN DIN 02347407
Health Canada record
| Active ingredient(s) | GAMITHROMYCIN 150 MG |
|---|---|
| Dosage form | Solution |
| Route | Subcutaneous |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 10-Aug-2010 |
| Current status date | 07-Aug-2025 |
| Source | Health Canada DPD |
Establishment licence of the holder
Boehringer Ingelheim (Canada) Ltd Ltee — licence 100187, currently licensed, last inspection rating C (2025-03-03).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 23686 | 2020-05-29 | New Drug Submission (NDS) | Administrative: Manufacturer Name Change |
| 11177 | 2010-03-29 | New Drug Submission (NDS) |